Skip to main content
Evaluno
3a check

How good is your pillar 3a?

Choose your 3a fund or account and see straight away whether you are paying too much in fees and how its performance compares.

  • 100 % independent and transparent
  • Over 450 products from 110 providers
  • Straight to the result, no sign-up

What your check looks like

Choose your product to see where it stands on costs and performance.

The entire Swiss pillar 3a market in one comparison

neon
finpension
SZKB - Schwyzer Kantonalbank
frankly
VIAC
ZKB - Zürcher Kantonalbank
Descartes
TKB - Thurgauer Kantonalbank
Swiss Life
True Wealth
UBS
Migros Bank
SGKB - St. Galler Kantonalbank
Bank Cler
BKB - Basler Kantonalbank
PostFinance
Raiffeisen
Valiant Bank
Alpian
BLKB - Basellandschaftliche Kantonalbank
Baloise Bank
relevate by PensExpert
VZ Vermögenszentrum
AKB - Aargauische Kantonalbank
BCGE - Banque Cantonale de Genève
BEKB - Berner Kantonalbank
LibertyGreen
Pilla by Crédit Agricole next bank
Zuger Kantonalbank
BCV - Banque Cantonale Vaudoise
fluks by LUKB
GKB - Graubündner Kantonalbank
Helvetia Versicherungen
Tellco
Yuh
Zak by CLER
Zurich Insurance Group
Die Mobiliar
Generali Investments
GKB Gioia 3a

How the 3a check works

You choose your product, and Evaluno compares it with over 450 pillar 3a accounts and funds. You see how your fees compare, what performance your product has achieved and which products with a similar equity share were cheaper or performed better. Free, with no sign-up required.

Updated on
  1. Choose your product

    First the provider, then your 3a account or fund. Evaluno lists over 450 products from over 110 providers.

  2. Put the result in context

    The check shows where your product stands on total costs and performance, across the whole market or only among products with a similar equity share.

  3. Review the alternatives

    The ten best products at your risk level, sorted by performance or fees. Filters show other levels or only products labelled sustainable.

Frequently asked questions

The check compares your product with all 3a funds in the Evaluno comparison or only with similar products, meaning funds at the same risk level (measured by equity share). If your fund is labelled sustainable, only funds that are also labelled sustainable count in this narrower group. The result shows how many products are cheaper or performed better, and where your product sits on the scale between the cheapest and the most expensive, or between the best and the worst. The check compares 3a accounts only with other 3a accounts, by interest rate.

It is based on the equity share (= the share of the money invested in equities): very low up to 20 %, low 21 to 40 %, medium 41 to 60 %, high 61 to 80 %, very high from 81 %. 3a accounts carry no price risk. The level does not take other risks into account, such as foreign currencies.

The annual fees as a percentage of your assets: product costs (TER, = the fund’s annual running costs), custody fees and other fees. One-off costs such as issue or redemption fees are not included. You can find them in the product details on the comparison page.

From the providers’ websites, product documents and information supplied directly by the providers. Each product shows the date of its data. Performance refers to the past and says nothing about the future.

Evaluno lists over 400 pillar 3a products, but not every one. Use the contact form to tell Evaluno which product you have. Evaluno will check whether it fits into the comparison.

Yes. The order depends only on performance, total costs or interest rate. Promo codes and partnerships have no influence on which products appear or where they rank.

Legal disclaimer

Evaluno does not provide investment, legal or tax advice and is no substitute for personal advice.

Independence guarantee

Evaluno is committed to neutrality.

  • Providers cannot buy a better ranking on Evaluno or influence its assessments.
  • Editorial content and comparisons are based exclusively on verifiable facts.
  • Partnerships and advertising are always labelled and have no influence on the published results.